{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:34:17Z","timestamp":1790807657171,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000454"],"award-info":[{"award-number":["UL1TR000454"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RF1AG051514-01"],"award-info":[{"award-number":["1RF1AG051514-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 T32 NS007480-14"],"award-info":[{"award-number":["5 T32 NS007480-14"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006528","name":"Alzheimer's Disease Research Center, Emory University","doi-asserted-by":"publisher","award":["P50 AG025688"],"award-info":[{"award-number":["P50 AG025688"]}],"id":[{"id":"10.13039\/100006528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.nbd.2017.02.010","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T13:16:13Z","timestamp":1487942173000},"page":"81-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"special_numbering":"C","title":["Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice"],"prefix":"10.1016","volume":"102","author":[{"given":"Kathryn P.","family":"MacPherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradoldej","family":"Sompol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Kannarkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Sniffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Wildner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mal\u00fa G.","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2017.02.010_bb0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.nbd.2017.02.010_bb0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J. Exp. Med."},{"issue":"30","key":"10.1016\/j.nbd.2017.02.010_bb0015","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1523\/JNEUROSCI.1496-12.2012","article-title":"Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology","volume":"32","author":"Bachstetter","year":"2012","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2017.02.010_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-140410","article-title":"Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro(R)1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats","volume":"4","author":"Barnum","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2017.02.010_bb0025","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Commun."},{"issue":"Pt 9","key":"10.1016\/j.nbd.2017.02.010_bb0030","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination","volume":"134","author":"Brambilla","year":"2011","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nbd.2017.02.010_bb0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","article-title":"Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview","volume":"50","author":"Brosseron","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2017.02.010_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coph.2015.10.003","article-title":"Linking T cells to Alzheimer's disease: from neurodegeneration to neurorepair","volume":"26","author":"Bryson","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"21","key":"10.1016\/j.nbd.2017.02.010_bb0045","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2017.02.010_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12252-4","article-title":"Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro","volume":"203","author":"Cunningham","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.nbd.2017.02.010_bb0055","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/glia.23005","article-title":"A case of mistaken identity: CD11c-eYFP(+) cells in the normal mouse brain parenchyma and neural retina display the phenotype of microglia, not dendritic cells","volume":"64","author":"Dando","year":"2016","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.nbd.2017.02.010_bb0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/icb.2010.12","article-title":"TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses","volume":"88","author":"Evangelidou","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.nbd.2017.02.010_bb0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2005-7304","article-title":"Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients","volume":"7","author":"Fiala","year":"2005","journal-title":"J. Alzheimers Dis."},{"issue":"46","key":"10.1016\/j.nbd.2017.02.010_bb0075","doi-asserted-by":"crossref","first-page":"16129","DOI":"10.1523\/JNEUROSCI.2323-12.2012","article-title":"Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease","volume":"32","author":"Furman","year":"2012","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2017.02.010_bb0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/187152710791011982","article-title":"Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease","volume":"9","author":"Hickman","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"10","key":"10.1016\/j.nbd.2017.02.010_bb0090","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.nbd.2017.02.010_bb0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbadis.2016.07.007","article-title":"Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease","volume":"1862","author":"Kamphuis","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.nbd.2017.02.010_bb0100","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.neurobiolaging.2015.02.006","article-title":"Age-related changes in regulator of G-protein signaling (RGS)-10 expression in peripheral and central immune cells may influence the risk for age-related degeneration","volume":"36","author":"Kannarkat","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0105","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s11481-013-9470-8","article-title":"Drainage of cells and soluble antigen from the CNS to regional lymph nodes","volume":"8","author":"Laman","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"7560","key":"10.1016\/j.nbd.2017.02.010_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.nbd.2017.02.010_bb0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","article-title":"TNF receptor subtype signalling: differences and cellular consequences","volume":"14","author":"MacEwan","year":"2002","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.nbd.2017.02.010_bb0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","article-title":"Microglia and inflammation in Alzheimer's disease","volume":"9","author":"Mandrekar-Colucci","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.nbd.2017.02.010_bb0125","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.02.010_bb0130","article-title":"Preparation of acute hippocampal slices from rats and transgenic mice for the study of synaptic alterations during aging and amyloid pathology","volume":"49","author":"Mathis","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.nbd.2017.02.010_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.02.010_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-5-45","article-title":"TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease","volume":"5","author":"McCoy","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"37","key":"10.1016\/j.nbd.2017.02.010_bb0145","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2017.02.010_bb0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.nbd.2017.02.010_bb0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0160","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ajpath.2011.07.001","article-title":"Ablation of TNF-RI\/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-alpha suppressive therapeutic strategies in the brain","volume":"179","author":"Montgomery","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.nbd.2017.02.010_bb0165","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ajpath.2013.02.030","article-title":"Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies","volume":"182","author":"Montgomery","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0170","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0306-4522(99)00225-0","article-title":"Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier","volume":"93","author":"Nadeau","year":"1999","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.nbd.2017.02.010_bb0175","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1096\/fj.11-202457","article-title":"Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease","volume":"26","author":"Naude","year":"2012","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.nbd.2017.02.010_bb0180","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"40","key":"10.1016\/j.nbd.2017.02.010_bb0185","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jnr.490330407","article-title":"MHC class II-positive microglia in human brain: association with Alzheimer lesions","volume":"33","author":"Perlmutter","year":"1992","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0195","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.nbd.2017.02.010_bb0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0205","first-page":"462","article-title":"CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?","volume":"4","author":"Rezai-Zadeh","year":"2009","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.nbd.2017.02.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101815","article-title":"Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions","volume":"9","author":"Rochfort","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nbd.2017.02.010_bb0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/cyto.a.22012","article-title":"A novel Ly6C\/Ly6G-based strategy to analyze the mouse splenic myeloid compartment","volume":"81","author":"Rose","year":"2012","journal-title":"Cytometry A"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2017.02.010_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2007.05.011","article-title":"Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration","volume":"188","author":"Rosenkranz","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.nbd.2017.02.010_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038170","article-title":"Inhibition of soluble tumor necrosis factor ameliorates synaptic alterations and Ca2+ dysregulation in aged rats","volume":"7","author":"Sama","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.nbd.2017.02.010_bb0230","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.88.16.7438","article-title":"Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system","volume":"88","author":"Sedgwick","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5641","key":"10.1016\/j.nbd.2017.02.010_bb0235","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"Steed","year":"2003","journal-title":"Science"},{"issue":"258","key":"10.1016\/j.nbd.2017.02.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003898","article-title":"Inflammatory cytokines at the summits of pathological signal cascades in brain diseases","volume":"6","author":"Steinman","year":"2013","journal-title":"Sci. Signal."},{"issue":"10","key":"10.1016\/j.nbd.2017.02.010_bb0245","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2017.02.010_bb0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.nbd.2017.02.010_bb0255","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1084\/jem.20150478","article-title":"Replacement of brain-resident myeloid cells does not alter cerebral amyloid-beta deposition in mouse models of Alzheimer's disease","volume":"212","author":"Varvel","year":"2015","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.nbd.2017.02.010_bb0260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jmcb\/mjp001","article-title":"How diverse\u2014CD4 effector T cells and their functions","volume":"1","author":"Wan","year":"2009","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2017.02.010_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1742-2094-11-57","article-title":"Comparison of microglia and infiltrating CD11c(+) cells as antigen presenting cells for T cell proliferation and cytokine response","volume":"11","author":"Wlodarczyk","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.nbd.2017.02.010_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomark. Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117300396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117300396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:34:28Z","timestamp":1777602868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117300396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":54,"alternative-id":["S0969996117300396"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.02.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}